Related references
Note: Only part of the references are listed.Lymphatic vessel assembly is impaired in Aspp 1-deficient mouse embryos
Masanori Hirashima et al.
DEVELOPMENTAL BIOLOGY (2008)
Drosophila ASPP regulates C-terminal Src kinase activity
Paul F. Langton et al.
DEVELOPMENTAL CELL (2007)
The ever expanding role for c-Myc in promoting genomic instability
Edward V. Prochownik et al.
CELL CYCLE (2007)
p53: Guardian of the genome and policeman of the oncogenes
Alejo Efeyan et al.
CELL CYCLE (2007)
ASPP: a new family of oncogenes and tumour suppressor genes
A. Sullivan et al.
BRITISH JOURNAL OF CANCER (2007)
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Sylvie Giuriato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
ASPP2 - A gene that controls life and death in vivo
Virginie Vives et al.
CELL CYCLE (2006)
ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth
Virginie Vives et al.
GENES & DEVELOPMENT (2006)
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes
MA Cobleigh et al.
CLINICAL CANCER RESEARCH (2005)
Control of ASPP2/53BP2L protein levels by proteasomal degradation modulates p53 apoptotic function
ZY Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F
T Hershko et al.
CELL DEATH AND DIFFERENTIATION (2005)
ASPP1 and ASPP2 are new transcriptional targets of E2F
V Fogal et al.
CELL DEATH AND DIFFERENTIATION (2005)
Downregulated mRNA expression of ASPP and the hypermethylation of the 5′-untranslated region in cancer cell lines retaining wild-type p53
ZJ Liu et al.
FEBS LETTERS (2005)
Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis
YH Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing
N Takahashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
ASPP1 and ASPP2: Common activators of p53 family members
D Bergamaschi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
被撤回的出版物: Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly (Retracted article. See vol. 73, pg. 1084, 2019)
SA Sarraf et al.
MOLECULAR CELL (2004)
Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins
SEM Meek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human
D Bergamaschi et al.
NATURE GENETICS (2003)
Immunotherapy as a therapeutic treatment for neurodegenerative disorders
AR White et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Adult blood vessels restore host hematopoiesis following lethal irradiation
MJ Montfort et al.
EXPERIMENTAL HEMATOLOGY (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome
IS Lossos et al.
LEUKEMIA & LYMPHOMA (2002)
ASPP proteins specifically stimulate the apoptotic function of p53
Y Samuels-Lev et al.
MOLECULAR CELL (2001)
Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains
X Espanel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Gene-expression profiles in hereditary breast cancer.
I Hedenfalk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53
CD Lopez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines
T Mori et al.
FEBS LETTERS (2000)
Share Paper
